NLRP3 and atrial fibrillation: Enhanced activation of NLRP3-inflammasome in AMs increases caspase-1 cleavage and caspase-1-mediated apoptosis, releases inflammatory cytokines, recruits macrophages and other immune cells, and induces myocardial fibrosis and promotes the formation of AF maintenance substrates (11).